[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Williams et al., 2010 - Google Patents

Cellular factors involved in HIV-1 RNA transport

Williams et al., 2010

Document ID
2882106681680514096
Author
Williams C
Lever A
Abbink T
Publication year
Publication venue
Rescent Advances in Human Retroviruses: Principles of Replication and Pathogenesis. World Scientific Publishing Co

External Links

Snippet

SUMMARY HIV-1 assembly and genomic RNA encapsidation have been intensively studied for many years. Many details of the interaction between the RNA packaging signal and the nucleocapsid (NC) domain of the structural Gag protein are now understood. However, there …
Continue reading at books.google.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid

Similar Documents

Publication Publication Date Title
Strebel et al. Human cellular restriction factors that target HIV-1 replication
Matreyek et al. The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid
Warrilow et al. Maturation of the HIV reverse transcription complex: putting the jigsaw together
Sloan et al. The role of unintegrated DNA in HIV infection
Gelderblom et al. Viral complementation allows HIV-1 replication without integration
Andersen et al. HIV-1 Vpr: mechanisms of G2 arrest and apoptosis
Valera et al. The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation
Klockow et al. The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection
Izumi et al. Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity
Yuan et al. An HIV-1 capsid binding protein TRIM11 accelerates viral uncoating
Rao et al. HIV-1 requires Staufen1 to dissociate stress granules and to produce infectious viral particles
Nekorchuk et al. HIV relies on neddylation for ubiquitin ligase-mediated functions
Ajasin et al. CCL2 mobilizes ALIX to facilitate Gag-p6 mediated HIV-1 virion release
Caly et al. Impaired nuclear import and viral incorporation of Vpr derived from a HIV long-term non-progressor
Arizala et al. Nucleolar localization of HIV-1 Rev is required, yet insufficient for production of infectious viral particles
Schweitzer et al. Knockdown of the cellular protein LRPPRC attenuates HIV-1 infection
Vanegas-Torres et al. HIV-1 Vpr Functions in Primary CD4+ T Cells
Ariumi et al. Ataxia-telangiectasia-mutated (ATM) protein can enhance human immunodeficiency virus type 1 replication by stimulating Rev function
Joshi et al. Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy
Williams et al. Cellular factors involved in HIV-1 RNA transport
Xiong et al. C19ORF66 is an interferon-stimulated gene (ISG) which Inhibits human immunodeficiency virus-1
Rohlfes et al. The nuclear localization signal of CPSF6 governs post-nuclear import steps of HIV-1 infection
Belzile Manipulation of the ubiquitin-proteasome system by HIV-1: role of the accessory protein Vpr
Irwan Reversal of Epigenetic Silencing by the SMC5/6 Complex Rescues Integrase-Deficient HIV-1 Replication and Prevents the Establishment of a Latent Reservoir
Berro The role of acetylated Tat in HIV-1 mRNA splicing